Developing novel acid-sensing ion channel inhibitors as neuroprotective leads and diagnostic agents for multiple sclerosis (2022–2024)
- Grant type:
- Multiple Sclerosis Research Australia - Targeted Grant - Neurodegeneration
- Researchers:
-
-
-
-
-
Associate Professor
School of Biomedical SciencesFaculty of Medicine -
Viertel Snr Medical Research Fellow
School of Biomedical SciencesFaculty of MedicinePrincipal Research Fellow
Queensland Brain Institute -
-
- Funded by:
- Multiple Sclerosis Research Australia
